Agenda

Day 1 | Wednesday 1st November

8:30 - Coffee & Registration

9:00 - Clearing and uncleared margins: today and tomorrow

  • Introduction, background, drivers to EMIR
  • Market trends in OTC derivatives
  • Current status of EU mandates
  • EMIR review
  • Fintech - distributed single ledger
  • Brexit - potential impact on clearing
  • Are futures the future?

Arvind Kannan, Principal Advisor, Financial Services Consulting, KPMG

10:30 - Coffee Break

11:00 - Clearing Members & the Margining operational set-up

  • Explaining the clearing member
    • What does a clearing member do? 
    • Why does it have clients? 
  • How do clearing members run their business?
  • Account set-up
  • Role of exchanges
  • Improving your operational set-up
  • Calculating IM & VM
  • Different methodologies & efficiency 

Alexander Jacobs, Head of OTC Clearing, ABN AMRO

12:30 - Lunch

13:30 - Non-Cleared Margin Rules: update on Regulatory and Legal Framework

  • What is happening in Brussels 
  • EMIR refit, reclassification of covered entities, and reporting
  • CCP supervision and new role of ESMA
  • New approach to third countries
  • Brexit and the aftermath
  • What does all this mean for covered entities?

Giuseppe Insalaco, Senior Advisor, Markets Policy Division, Policy & Risk Directorate, Central Bank of Ireland

15:00 - Coffee Break

15:30 - CCPs: Managing Risk & Future-Proofing

  • Equivalence and CCP choice
  • Voluntary clearing versus mandatory clearing - what's happening and what is driving it
  • How CCPs are different / how are CCPs competing
  • Initial Margin models
  • Cross margining vs Portfolio Margining
  • Using a Clearing broker Vs membership Vs a sponsored access model
    CCP developments in near future (products / models / structures)
  • Impact of UMR on clearing - more volumes / more products / futurization?
  • Default Management - Risk waterfalls & CCP interaction

Phil Hermon, Senior Director, OTC Products, CME GROUP & David Nicolay, Senior Director, Quant Risk Management, CME Group

17:00 - End of Day 1

Day 2  | Thursday 2nd November 

8:30 - Coffee & Registration

09:00 - From Compliance to Optimisation

  • Building a plan: moving from tactical single solutions to a strategic encompassing solution 
  • Short term vs. long term
  • Default management & BAU porting
  • Collateral management challenges (optimisation, transformation, liquidity)
  • Managing the transition from non-cleared to cleared 
  • Clearing 100%

John Lund, Consultant, Derivatives & Collateral Management, JXL Consulting

10:30 - Coffee Break

11:00 - The costs of Clearing and the Clearing Broker relationship

  • Review of operational costs & capital requirements
  • Portfolio Modelling (Initial Margin & Collateral)
  • MVA: Funding costs of initial margin
  • How to be efficient with your clearing strategy
  • Clearing Member & CCP fee models 
  • Negotiating your clearing broker relationship

Phil Hermon, Senior Director, OTC Products, CME Group & Jamie Gavin, Global Head of OTC Clearing, Société Générale

12:30 - Lunch

13:30 - Collateral Management

  • Sourcing collateral to meet demand
  • Collateral optimisation & transformation
  • Managing collateral during transition period
  • Predicting your requirements
  • Constraints in new environment
  • Industry utilities

Matteo Rolle, Senior Director, Head of In Business Risk, Capital & Collateral, Lloyds Banking Group

15:00 - Coffee & Networking

15:30 - End of Training Course

Q4 Risk Training Calendar
Bespoke Training:
Request a Call Back!